Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Elizabeth E. Hopp MD

Elizabeth E. Hopp MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Obstetrics and Gynecology
Division: Obstetrics and Gynecology Gynecologic Oncology

Member of the Cancer Center

View Curriculum Vitae

Publications (24)

  • Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours. (Grisham RN, Hopp E, Pennington K, Holloway R, Wenham RM, Blecharz P, Dockery L, Matsuo K, Salani R, Bidzinski M, Braly P, Celano P, Reid T, Seward S, Lewis J, Johnson M, DuBose R, Ahn S, Cheng S, Alvero C, Konstantinopoulos PA) Clin Transl Med 2026 Jan;16(1):e70568 PMID: 41518037 PMCID: PMC12789897 01/10/2026    
  • Combination Hormonal Drug Therapy Inhibits In Vitro Growth of Adult Ovarian Granulosa Tumor Cells. (Summey RM, Iden M, Tsaih SW, Schmidt R, Parashar D, Wang S, Rader JS, Hopp E) Cancer Invest 2026 Mar;44(3):279-295 PMID: 41451785 SCOPUS ID: 2-s2.0-105026769794 12/26/2025    
  • Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer. (Kim H, Deng W, Zamarin D, Xiao Y, Chino J, Benedict S, Nguyen H, Lowenstein J, McNulty S, Ghamande S, Ferguson C, Mell L, Holman LL, Mathews C, Quick A, Olawaiye A, Hopp E, Mannel R, Leath III CA, O'Cearbhaill RE, Aghajanian C, Schilder RJ, Mayadev J) Brachytherapy 2026;25(1):127-135 PMID: 41107078 PMCID: PMC12971087 SCOPUS ID: 2-s2.0-105019104601 10/18/2025       1 Citation
  • Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial (Olawaiye AB, Gladieff L, O'Malley DM, Kim JW, Garbaos G, Salutari V, Gilbert L, Mileshkin L, Devaux A, Hopp E, Lee YJ, Oaknin A, Scaranti M, Kim BG, Colombo N, McCollum ME, Diakos C, Clamp A, Leiser AL, Balázs B, Monk BJ, Scandurra G, McClung E, Kaczmarek E, Slomovitz B, De La Cueva H, de Carvalho Calabrich AF, Cassani C, You B, Van Gorp T, Churruca C, Caruso G, Nicum S, Bagaméri A, Artioli G, Bodnar L, Kang S, Vergote I, Kesner-Hays A, Pashova HI, Pai SG, Tudor IC, Jubb AM, Lorusso D) Lancet 21 June 2025;405(10496):2205-2216 SCOPUS ID: 2-s2.0-105007158427 06/21/2025       24 Citations
  • Characterizing platinum resistance in recurrent endometrial cancer: A retrospective cohort study. ASCO Online Abstract 2025 in Journal of Clinical Oncology (Camilla Dagum, Mitchell Depke, Brittany Derynda, Emmy Lambert, Nathan Deep, Carolyn Storch, Melodee Liegl, Amy Pan, Elizabeth Hopp) Journal of Clinical Oncology Camilla Dagum et al. Characterizing platinum resistance in recurrent endometrial cancer: A retrospective cohort study.. J Clin Oncol 43, e17620-e17620(2025). DOI:10.1200/JCO.2025.43.16_suppl.e17620 05/28/2025    
  • Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial. (Lee JM, Miller A, Rose PG, AlHilli M, Washington C, John VS, Shah CA, Matsuo K, Siedel J, Miller DS, Hopp EE, O'Shea A, Chan JK, Bradford LS, Morse CB, Nagel CI, Rodabaugh KJ, Kohn EC, Moore KN, Liu JF) Clin Cancer Res 2025 Jun 13;31(12):2370-2378 PMID: 40192715 PMCID: PMC12165816 SCOPUS ID: 2-s2.0-105008776673 04/07/2025       4 Citations
  • Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. (Mayadev J, Zamarin D, Deng W, Lankes HA, Pesci G, Kim H, Chino JP, Banbury B, Sherry N, Sharon E, Ghamande SA, Ferguson C, Mell L, Holman L, Mathews C, O'Malley D, Olawaiye A, Hopp E, Leath C 3rd, Copeland L, Mannel R, O'Cearbhaill R, Aghajanian C, Schilder RJ) Nat Commun 2025 Jan 09;16(1):553 PMID: 39788967 PMCID: PMC11718273 SCOPUS ID: 2-s2.0-85214887481 01/10/2025       10 Citations
  • Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult-type ovarian granulosa cell tumors. (Summey RM, Gornstein E, Decker B, Dougherty KC, Rader JS, Hopp E) Cancer Med 2024 Jun;13(12):e7340 PMID: 38898688 PMCID: PMC11187164 SCOPUS ID: 2-s2.0-85196521716 06/20/2024       2 Citations
  • Clinicopathologic Characteristics of a Single-institution Cohort of Ovarian Adult Granulosa Cell Tumors, With Biomarker and Therapeutic Implications Utilizing the Detection of Androgen, Estrogen, and Progesterone Hormone Receptor Expression by Immunohistochemistry. (Moh M, Puzyrenko A, Summey R, Rader JS, Herrera Cano GE, Gavina JV, Rui H, Sun Y, Hopp E) Int J Gynecol Pathol 2024 Sep 01;43(5):527-534 PMID: 38661526 SCOPUS ID: 2-s2.0-85201753022 04/25/2024       2 Citations
  • Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer (Uyar D, Michener CM, Bishop E, Hopp E, Simpson P, Zhang L, Rader JS, Rose PG, Mahdi HS, Debernardo R, Christian Q, Bradley W) Frontiers in Oncology 2024;14 SCOPUS ID: 2-s2.0-85186485797 01/01/2024       1 Citation
  • A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor (Summey RM, Rader JS, Moh M, Bradley W, Uyar D, Bishop E, McAlarnen L, Hopp E) Gynecologic Oncology Reports December 2022;44 SCOPUS ID: 2-s2.0-85144072474 12/01/2022       7 Citations
  • Same-Day Discharge After Robotic Hysterectomy: A Resource Utilization and Quality Improvement Project. (McAlarnen LA, Maurer JE, Knaub A, Hopp E, Streitenberger K, Bishop E, Bradley W, Rader J, Uyar D) WMJ 2022 Oct;121(3):243-246 PMID: 36301654 SCOPUS ID: 2-s2.0-85140865266 10/28/2022       4 Citations
  • Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958. (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P) Cancers (Basel) 2022 May 16;14(10) PMID: 35626175 PMCID: PMC9140135 SCOPUS ID: 2-s2.0-85129951244 05/29/2022       2 Citations
  • Correction to: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance (Cancers, (2022), 14, 958) (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P) Cancers May-2 2022;14(10) SCOPUS ID: 2-s2.0-85129951244 05/01/2022       2 Citations
  • Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P) Cancers (Basel) 2022 Feb 15;14(4) PMID: 35205706 PMCID: PMC8870411 SCOPUS ID: 2-s2.0-85124460063 02/26/2022       18 Citations
  • Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P) Cancers February-2 2022;14(4) SCOPUS ID: 2-s2.0-85124460063 02/01/2022       18 Citations
  • Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum. (McAlarnen LA, Tsaih SW, Aliani R, Simske NM, Hopp EE) Gynecol Oncol 2021 Jul;162(1):4-11 PMID: 33994014 PMCID: PMC8111476 SCOPUS ID: 2-s2.0-85105799766 05/18/2021       22 Citations
  • Improving Value-Based Care Education in a Fellowship by Incorporating ACGME Competencies (Kristine Zanotti, Sahana Somasegar, Monica Webb Hooper and Elizabeth Hopp) Journal of Graduate Medical Education Kristine Zanotti, Sahana Somasegar, Monica Webb Hooper, and Elizabeth Hopp. Improving Value-Based Care Education in a Fellowship by Incorporating ACGME Competencies. Journal of Graduate Medical Education 2019 11:6, 668-673. 12/02/2019    
  • Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features. (Hopp EE, Cossette SM, Kumar SN, Eastwood D, Ramchandran R, Bishop E) Cancer Invest 2017 Aug 09;35(7):456-462 PMID: 28722495 PMCID: PMC6167932 SCOPUS ID: 2-s2.0-85025168444 07/20/2017       5 Citations
  • Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression. (Liu P, Iden M, Fye S, Huang YW, Hopp E, Chu C, Lu Y, Rader JS) Cancer Epidemiol Biomarkers Prev 2017 Apr;26(4):642-650 PMID: 28069683 SCOPUS ID: 2-s2.0-85016990220 01/11/2017       23 Citations
  • A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer. (Hopp EE, Osborne JL, Schneider DK, Bojar CJ, Uyar DS) Gynecol Oncol Rep 2016 Jan;15:25-8 PMID: 26937484 PMCID: PMC4750017 SCOPUS ID: 2-s2.0-84964714816 03/05/2016       26 Citations
  • Small bowel obstruction after vaginal hysterectomy with bilateral salpingo-oophorectomy (Palatnik A, Hopp EE, Hoogerland D) Journal of Gynecologic Surgery 1 October 2012;28(5):372-374 SCOPUS ID: 2-s2.0-84868033301 10/01/2012    
  • Effect of a best-practice alert on the rate of influenza vaccination of pregnant women. (Klatt TE, Hopp E) Obstet Gynecol 2012 Feb;119(2 Pt 1):301-5 PMID: 22270281 SCOPUS ID: 2-s2.0-84856488608 01/25/2012       60 Citations
  • Regulation of glycosyltransferase genes in apoptotic breast cancer cells induced by L: -PPMP and cisplatin. (Ma R, Hopp EA, Decker NM, Loucks A, Johnson JR, Moskal J, Basu M, Banerjee S, Basu S) Adv Exp Med Biol 2011;705:621-42 PMID: 21618133 SCOPUS ID: 2-s2.0-80054017009 05/28/2011       4 Citations
    • Last update: 02/04/2026